Envestnet Asset Management’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.5M Sell
56,975
-1,245
-2% -$523K 0.01% 1235
2026
Q1
$22M Sell
58,220
-4,944
-8% -$2.12M 0.01% 1288
2025
Q4
$27M Sell
63,164
-16,916
-21% -$7.36M 0.01% 1045
2025
Q3
$35.9M Buy
80,080
+4,865
+6% +$2.2M 0.01% 923
2025
Q2
$36.6M Sell
75,215
-4,908
-6% -$2.8M 0.01% 897
2025
Q1
$49.3M Buy
80,123
+3,695
+5% +$2.1M 0.02% 720
2024
Q4
$40.5M Sell
76,428
-1,408
-2% -$794K 0.01% 813
2024
Q3
$46.8M Buy
77,836
+3,375
+5% +$1.91M 0.02% 751
2024
Q2
$40.4M Buy
74,461
+1,106
+2% +$634K 0.01% 765
2024
Q1
$47.1M Buy
73,355
+124
+0.2% +$75.3K 0.02% 693
2023
Q4
$42.8M Buy
73,231
+1,800
+3% +$1.01M 0.02% 674
2023
Q3
$37.1M Buy
71,431
+19,785
+38% +$10.3M 0.02% 674
2023
Q2
$28M Sell
51,646
-426,192
-89% -$233M 0.01% 762
2023
Q1
$26.5M Buy
477,838
+426,167
+825% +$217M 0.01% 749
2022
Q4
$26.4M Buy
51,671
+711
+1% +$346K 0.01% 717
2022
Q3
$22.2M Buy
50,960
+748
+1% +$360K 0.01% 726
2022
Q2
$23.6M Buy
50,212
+60
+0.1% +$29.3K 0.01% 702
2022
Q1
$25.4M Buy
50,152
+4,972
+11% +$2.38M 0.01% 745
2021
Q4
$23.9M Sell
45,180
-526
-1% -$253K 0.01% 764
2021
Q3
$21.3M Sell
45,706
-26,255
-36% -$12.4M 0.01% 777
2021
Q2
$34.1M Buy
71,961
+8,077
+13% +$3.88M 0.02% 582
2021
Q1
$29.4M Buy
63,884
+3,969
+7% +$1.95M 0.02% 580
2020
Q4
$31.9M Buy
59,915
+2,942
+5% +$1.45M 0.02% 472
2020
Q3
$27.4M Buy
56,973
+9,284
+19% +$4.55M 0.02% 455
2020
Q2
$21.5M Buy
47,689
+6,064
+15% +$2.71M 0.02% 493
2020
Q1
$18M Buy
41,625
+6,214
+18% +$2.77M 0.02% 476
2019
Q4
$15.6M Buy
35,411
+2,027
+6% +$853K 0.02% 614
2019
Q3
$13.9M Buy
33,384
+289
+0.9% +$118K 0.02% 611
2019
Q2
$11.9M Buy
33,095
+2,555
+8% +$854K 0.02% 654
2019
Q1
$9.78M Buy
30,540
+1,869
+7% +$574K 0.01% 697
2018
Q4
$8.12M Buy
28,671
+28,017
+4,284% +$8.46M 0.01% 676
2018
Q3
$209K Sell
654
-11,063
-94% -$3.53M ﹤0.01% 1163
2018
Q2
$3.77M Sell
11,717
-980
-8% -$307K 0.01% 582
2018
Q1
$3.52M Sell
12,697
-8,394
-40% -$2.22M 0.01% 503
2017
Q4
$5.13M Sell
21,091
-257
-1% -$58.4K 0.01% 585
2017
Q3
$4.31M Sell
21,348
-6,215
-23% -$1.22M 0.01% 609
2017
Q2
$5.64M Buy
27,563
+557
+2% +$111K 0.02% 529
2017
Q1
$4.93M Sell
27,006
-1,696
-6% -$296K 0.02% 577
2016
Q4
$4.6M Buy
28,702
+386
+1% +$56.7K 0.02% 580
2016
Q3
$4M Sell
28,316
-13,005
-31% -$1.81M 0.02% 669
2016
Q2
$5.63M Buy
41,321
+826
+2% +$110K 0.02% 580
2016
Q1
$5.49M Sell
40,495
-4,529
-10% -$612K 0.02% 555
2015
Q4
$6.75M Buy
45,024
+2,663
+6% +$394K 0.03% 469
2015
Q3
$5.65M Buy
42,361
+7,405
+21% +$1.04M 0.03% 510
2015
Q2
$4.58M Buy
34,956
+1,027
+3% +$127K 0.02% 632
2015
Q1
$4.05M Buy
33,929
+33,858
+47,687% +$3.76M 0.02% 644
2014
Q4
$8K Sell
71
-27
-28% -$2.85K ﹤0.01% 2023
2014
Q3
$10K Sell
98
-80
-45% -$8.11K ﹤0.01% 2113
2014
Q2
$17K Buy
178
+129
+263% +$11.4K ﹤0.01% 1813
2014
Q1
$4K Sell
49
-73
-60% -$5.95K ﹤0.01% 2145
2013
Q4
$9K Hold
122
﹤0.01% 1781
2013
Q3
$9K Hold
122
﹤0.01% 1733
2013
Q2
$9K Buy
+122
New +$8.95K ﹤0.01% 1688

Other funds holding CHE

Envestnet Asset Management's CHE Position: Q2 2026 in Review

Envestnet Asset Management reduced its Chemed (CHE) stake by 2.1% in Q2 2026, selling an estimated $523K and leaving 56,975 shares worth $26.5M. The position accounts for 0.01% of the portfolio, ranked #1235.

Envestnet Asset Management first reported a position in CHE in Q2 2013 and has held it in 53 quarters since. The position peaked at $49.3M in Q1 2025. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Envestnet Asset Management held 56,975 shares of Chemed worth $26.5M as of Q2 2026.
  • Envestnet Asset Management sold 1,245 Chemed shares in Q2 2026, an estimated $523K.
  • Chemed made up 0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #1235 holding.
  • Envestnet Asset Management first reported a position in Chemed in Q2 2013 and has held it in 53 quarters since.
  • Envestnet Asset Management's Chemed position peaked at $49.3M in Q1 2025.
  • 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.